Boeing recently announced that it has temporarily halted flight tests of its 777X aircraft after uncovering damage in a specific structure of one of the planes. The company identified the damage in a custom part located between the engine and the airplane structure during routine maintenance. As a precautionary measure, Boeing has also grounded the
0 Comments
As the bell rings to start the trading day, Jim Cramer’s Charitable Trust has made the decision to sell its remaining 330 shares in Estee Lauder. This move comes following disappointing fiscal 2025 guidance from the company. The decision to exit the position was influenced by the weaker sales and profit outlook for the new
0 Comments
Buffer ETFs have gained traction among investors as a way to hedge against recent market volatility. These exchange-traded funds offer a unique opportunity for individuals looking to gain exposure to the market while mitigating downside risk. CEO of Innovator ETFs, Bruce Bond, highlights the benefits of buffer ETFs in providing protection during uncertain market conditions.
0 Comments
The recent revelation by Gilead Sciences of a dangerous drug-counterfeiting operation has sent shockwaves through the pharmaceutical industry. The scheme, allegedly orchestrated by Peter Khaim, a notorious medical fraudster, involved tampering with HIV medications produced by Gilead and then improperly reselling them to unsuspecting patients. This discovery has raised serious concerns about the safety and
0 Comments